2022

• Brian W. Pogue, Phuong Vincent, Tayyaba Hasan, Kenneth Wang. Radiomic signatures of photodynamic priming in clinical pancreatic cancer treatment. 11940-1, SPIE January 2022, San Francisco.
• Girgis Obaid, Shazia Bano, Kimberley S. Samkoe, Imran Rizvi, Brian W. Pogue, David H. Kessel, Tayyaba Hasan. Targeting photonanomedicines in cancer therapy: stromal, cellular and subcellular photomodulation. 11940-43, SPIE January 2022, San Francisco.
• Barry J. Liang, Michael Pigula, Yan Baglo, Daniel Najafali, Tayyaba Hasan, Huang-Chiao Huang. Rationally designed light-activatable nanocomplex for multi-tier cancer cell targeting and photochemotherapy. 11940-18, SPIE January 2022, San Francisco.

2021

• Pushpamali De Silva, Mohammad Ahsan Saad, Zhiming Mai, Shazia Bano, Assiris P. Camargo, Tayyaba Hasan, Enrichment of photodynamically-primed anti-tumor immune infiltrates in pancreatic cancer: enabling enhanced immunotherapy. AACR Virtual Special Conference: Tumor Immunology and Immunotherapy, AACR, Virtual, 2021.
• Bryan Spring. Development of multiplexed microendoscopy to guide precision cancer medicine. ASP 2021 Symposium, June 8, 2021 (Conducted online).

2020

• Yuri Hanada, Juan Reyes Genere, Bryan Linn, Brian Pogue, Tayyaba Hasan, Kenneth K. Wang. Endoscopic Ultrasound Guided Verteporfin Photodynamic Therapy for Locally Advanced Pancreatic Cancer: Preliminary Phase II Trial Data. Gastroenterology, May 2020, 158, Issue 6, S-522–S-523, DOI: https://doi.org/10.1016/S0016-5085(20)31994-6
• Ethan Philip M. LaRochelle, Alberto J. Ruiz, M. Shane Chapman, Edward V. Maytin, Tayyaba Hasan, Brian W. Pogue. Clinical implementation of model-based dose planning for indoor daylight photodynamic therapy of skin (Conference Presentation). Proc. SPIE 11220, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIX, 1122006 (10 March 2020); https://doi.org/10.1117/12.2543536
• Tayyaba Hasan. Is PDT-based metastatic reduction a consequence of local tumor control or a true abscopal effect in immunodeficient mice? (Conference Presentation). Proc. SPIE 11220, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIX, 1122003 (10 March 2020);https://doi.org/10.1117/12.2549954
• Sanjay Anand, Mukul Govande, Anton Yasinchak, Lauren Heusinkveld, Sajina Shakya, Edward V. Maytin. Metronomic PDT induces innate and adaptive immune responses in murine models of skin cancer and pre-cancer. Proc. SPIE 11220, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIX, 112200I (21 February 2020);https://doi.org/10.1117/12.2553081
• Pushpamali De Silva, Mohammad Ahsan Saad, Assiris P. Camargo, Joseph Swain, Akilan Palanasami, Girgis Obaid, Shalin Shetty and Tayyaba Hasan. Abstract A17: Enhanced immune infiltration and antitumor immune reactivity in response to optical priming in pancreatic cancer. Cancer Immunology Research, 2020, 8 (3 Supplement), A17-A17. DOI: 10.1158/2326-6074.TUMIMM19-A17

2019

• Mohammad Saad, Marvin Xavierselvan, Hamza A Sharif, Srivalleesha Mallidi, Tayyaba Hasan. Dual function antibody conjugates (DFACs) for drug quantification and therapy (Conference Presentation). Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 1107011 (2019) doi: https://doi.org/10.1117/12.2528162
• Bhaskar Roy, Marlys Anderson, Juan Reyes Genere, Brian Pogue, Tayyaba Hasan, Kenneth K. Wang. Synergistic Effect of Verteporfin-Pdt with Gemcitabine on Pancreatic Cancer Cell Death In-Vitro. Gastroenterology, May 2019, Vol. 156, Issue 6, S-761.DOI: https://doi.org/10.1016/S0016-5085(19)38842-0
• Phuong Vincent, Kimberley Samkoe, Jason Gunn, Kayla Marra, Jack Hoopes, Tayyaba Hasan, Brian Pogue. Modifying pancreatic tumor stroma with angiotensin II receptor blockers to improve verteporfin delivery. Proc. SPIE 10860, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVIII, 108600P (28 February 2019); https://doi.org/10.1117/12.2508796

2018

• Phuong Vincent, Rui Xie, Michael Nieskoski, Kayla Marra, Jason Gunn, Brian W. Pogue. Verteporfin heterogeneity in pancreatic adenocarcinoma and the relationship to tumor vasculature and collagen distribution. Proc. SPIE 10476, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVII, 1047617 (12 February 2018);https://doi.org/10.1117/12.2309291

2017

• Kenneth K. Wang, Timothy R. Donahue, Gregory B. Haber, John M. DeWitt, Kenneth J. Chang Raj J. Shah, V. Raman Muthusamy, Amit Mahipal, Thomas Mang, Tayyaba Hasan, Vandana Grover. The Use of Photodynamic Therapy in Pancreatic Cancer: Consensus Statement from an Expert Panel. Gastroenterology 2017;152:S498. DOI: 10.1016/S0016-5085(17)31842-5
• Sanjay Anand, Taylor Bullock, Edward V. Maytin. Minimally toxic approach for treatment of cutaneous breast cancer metastases: capecitabine-enhanced photodynamic therapy. Proc. SPIE 10047, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI, 100470K (8 February 2017); https://doi.org/10.1117/12.2256511
• Ethan LaRochelle ; Scott Davis ; Ana Luiza Ribeiro de Souza ; Brian Pogue In vivo wide-field multispectral dosimeter for use in ALA-PpIX based photodynamic therapy of skin  Proc. SPIE. 10047, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI, Proceedings Article | 8 February 2017

2016

• E. V. Maytin, S. Anand, “Combination photodynamic therapy using 5-fluorouracil and aminolevulinate enhances tumor-selective production of protoporphyrin IX and improves treatment efficacy of squamous skin cancers and precancers” Proc. SPIE  9694, 96940E (2016); doi: 10.1117/12.2218138.
  
• S. Anand, Erik Thomas, Tayyaba Hasan, Edward V. Maytin, “Vitamin D for combination photodynamic therapy of skin cancer in individuals with vitamin D deficiency: Insights from a preclinical study in a mouse model of squamous cell carcinoma” Proc. SPIE  9694, 96940K (2016); doi: 10.1117/12.2214463.

2015

• S. Lagnojita, J. T. Elliott, T. Hasan, B. W. Pogue, K. S. Samkoe, K. M. Tichauer, “Early photosensitizer uptake kinetics predict optimum drug-light interval for photodynamic therapy,” Proc. SPIE, 9308, 930811 (2015), doi: 10.1117/12.2077842.
• E. V. Maytin, S. Anand, K. Rollakanti, “Clinical potential for vitamin D as a neoadjuvant for photodynamic therapy of nonmelanoma skin cancer,” Proc. SPIE, 9308, 93080H (2015), doi: 10.1117/12.2077234.
• K. Rollakanti, S. Anand, E. V. Maytin, “Topical calcitrol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models,” Proc. SPIE, 9308, 93080Q (2015), doi: 10.1117/12.2077296.
• B. W. Pogue, S. Gioux, “Molecular-guided surgery,” Proc. SPIE, 9311, 931102-5, doi: 10.1117/12.2190063.

2014

• S. C. Davis, K. Sexton, M. S. Chapman, E. Maytin, T. Hasan, B. W. Pogue, “Pulsed light imaging for wide-field dosimetry of photodynamic therapy in the skin,” Proc. SPIE, 8931, 89310W (2014), doi: 10.1117/12.2040174.
• A. V. DSouza, B. P. Flynn, J. R. Gunn, K. S. Samkoe, S. Anand, E. V. Maytin, T. Hasan, and B. W. Pogue, “ALA-PpIX variability quantitatively imaged in A431 epidermoid tumors using in vivo ultrasound fluorescence tomography and ex vivo assay,” Proc. SPIE, 8931, 893114 (2014), doi: 10.1117/12.2037800.

2013

• S. Anand, T. Hasan, and E. V. Maytin, “Mechanism of enhanced responses after combination photodynamic therapy (cPDT) in carcinoma cells involves C/EBP-mediated transcriptional upregulation of the coproporphyrinogen oxidase (CPO) gene,” Proc. SPIE, 856807-856807 (2013), doi: 10.1117/12.2004488.
• B. P. Flynn, A. V. D’Souza, S. C. Kanick, E. Maytin, T. Hasan, and B. W. Pogue, “Subsurface PpIX imaging in vivo with ultrasound-guided tomographic spectroscopy: reconstruction vs. born-normalized data,” Proc. SPIE, 856809-856809 (2013), doi: 10.1117/12.2007502.
• J. Gunn, K. Tichauer, K. Moodie, S. Kane, J. Hoopes, E. E. Stewart, J. Hadway, T.-Y. Lee, S. P. Pereira, and B. W. Pogue, “Pancreas tumor model in rabbit imaged by perfusion CT scans,” Proc. SPIE, 85681E-85681E (2013), doi: 10.1117/12.1518470.
• M. Jermyn, S. C. Davis, H. Dehghani, M. Huggett, T. Hasan, S. P. Pereira, and B. W. Pogue, “Photodynamic therapy light dose analysis of a patient based upon arterial and venous contrast CT scan information,” Proc. SPIE, 85680Z-85680Z (2013), doi: 10.1117/12.2004003.
• L. Mensah, S. Mallidi, I. Massodi, S. Anbil, Z. Mai, and T. Hasan, “Environmental effects on molecular biomarkers expression in pancreatic and brain cancer,” Proc. SPIE, 856803-856803 (2013), doi: 10.1117/12.2010697.
• E. V. Maytin, S. Lohser, A. Tellez, L. Wene, R. Ishak, S. Anand, “Clinical studies of combined photodynamic therapy using 5-fluorouracil and methyl-aminolevulinate in patients at high risk for squamous cell carcinoma,” Proc. SPIE  8568, 85680N (2013); doi: 10.1117/12.2001882.
• K. Rollakanti, S. Anand, E. V. Maytin,“In-vivo luminescence model for the study of tumor regression and regrowth following combination regimens with differentiation-promoting agents and photodynamic therapy,” Proc. SPIE  8568, 85680Y (2013); doi: 10.1117/12.2004637.
• A. V. D’Souza, B. P. Flynn, S. C. Kanick, S. Torosean, S. C. Davis, E. V. Maytin, T. Hasan, B. W. Pogue, “An ultrasound-guided fluorescence tomography system: design and specification,” Proc. SPIE  8568, 85681A (2013); doi: 10.1117/12.2007504

2012

• J. A. O’Hara, K. S. Samkoe, A. Chen, M. Isabelle, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Histologic differences between orthotopic xenograft pancreas models affect Verteporfin uptake measured by fluorescence microscopy and spectroscopy,” Proc. SPIE, 821014-821014 (2012), doi: 10.1117/12.913049.
• S. Torosean, B. Flynn, K. S. Samkoe, S. C. Davis, J. Gunn, J. Axelsson, and B. W. Pogue, “Double-excitation fluorescence spectral imaging: eliminating tissue auto-fluorescence from <i>in vivo</i> PPIX measurements,” Proc. SPIE, 82100Z-82100Z (2012), doi: 10.1117/12.909031.
• S. Torosean, B. Flynn, K. S. Samkoe, J. Gunn, J. Axelsson, M. Doyley, and B. W. Pogue, “A high frequency ultrasound aided study of kinetics of drug delivery in tumor models,” Proc. SPIE, 83200Y-83200Y (2012), doi: 10.1117/12.911954.

2011

• M. Isabelle, W. Klubben, T. He, A. M. Laughney, A. Glaser, V. Krishnaswamy, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Assessment of biophysical tumor response to PDT in pancreatic cancer using localized reflectance spectroscopy,” Proc. SPIE, 78860S-78860S (2011), doi: 10.1117/12.876147.
• V. Krishnaswamy, A. M. Laughney, K. D. Paulsen, and B. W. Pogue, “A dark-field scanning spectroscopy platform for localized scatter and fluorescence imaging of tissue,” Proc. SPIE, 79070J-79070J (2011), doi: 10.1117/12.875462.
• A. Paliwal, S. Torosean, J. Gruber, J. O’Hara, T. Hasan, B. Pogue, and E. V. Maytin, “In vivo validation of high frequency ultrasound-guided fluorescence tomography system to improve delivery of photodynamic therapy,” Proc. SPIE, 788610-788610 (2011), doi: 10.1117/12.875629.
• E. V. Maytin, S. Anand, C. Wilson, K. Iyer, “”5-Fluorouracil as an enhancer of aminolevulinate-based photodynamic therapy for skin cancer: New use for a venerable agent?” Proc. SPIE  7886, 78860K (2011); doi: 10.1117/12.874188.

2010

• P. B. Garcia-Allende, O. M. Conde, V. Krishnaswamy, P. J. Hoopes, B. W. Pogue, J. Mirapeix, and J. M. Lopez-Higuera, “Automated ensemble segmentation of epithelial proliferation, necrosis, and fibrosis using scatter tumor imaging,” Proc. SPIE, 77151B-77151B (2010), doi: 10.1117/12.854559.
• M. Isabelle, J. A. O’Hara, K. S. Samkoe, P. J. Hoopes, S. Mosse, S. Pereira, T. Hasan, and B. W. Pogue, “In vivo sampling of Verteporfin uptake in pancreas cancer xenograft models: comparison of surface, oral, and interstitial measurements,” Proc. SPIE, 755116-755116 (2010), doi: 10.1117/12.852779.
• B. W. Pogue, S. Srinivasan, K. Samkoe, L. Z. Zheng, P. Rai, Z. Mai, S. Verma, and T. Hasan, “Analytic modeling of antibody versus nanocell delivery of photosensitizer,” Proc. SPIE, 755117-755117 (2010), doi: 10.1117/12.853925.
• K. S. Samkoe, S. C. Davis, S. Srinivasan, M. E. Isabelle, J. O’Hara, T. Hasan, and B. W. Pogue, “EGF targeted fluorescence molecular tomography as a predictor of PDT outcomes in pancreas cancer models,” Proc. SPIE, 75510Q-75510Q (2010), doi: 10.1117/12.842934.
• K. S. Samkoe, S. K. Hextrum, O. Pardesi, J. A. O’Hara, T. Hasan, and B. W. Pogue, “Specific binding of molecularly targeted agents to pancreas tumors and impact on observed optical contrast,” Proc. SPIE, 75680H-75680H (2010), doi: 10.1117/12.843009.
• E. V. Maytin, S. Anand, N. Atanaskova, C. Wilson, “Vitamin D as a potential enhancer of aminolevulinate-based photodynamic therapy for nonmelanoma skin cancer,” Proc. SPIE  7551, 755105 (2010); doi: 10.1117/12.847183

2009

• P. B. Garcia-Allende, V. Krishnaswamy, K. S. Samkoe, P. J. Hoopes, B. W. Pogue, O. M. Conde, and J. M. Lopez-Higuera, “Automated segmentation based upon remitted scatter spectra from pathologically distinct tumor regions,” Proc. SPIE, 718717-718717 (2009), doi: 10.1117/12.808322.
• J. D. Gruber, V. Krishnaswamy, E. V. Maytin, T. Hasan, and B. W. Pogue, “System for fluorescence quantification of thin tissue layers guided by high frequency ultrasound,” Proc. SPIE, 71640N-71640N (2009), doi: 10.1117/12.809011.
• J. O’Hara, K. S. Samkoe, A. Chen, P. J. Hoopes, I. Rizvi, T. Hasan, and B. W. Pogue, “Uptake of verteporfin by orthotopic xenograft pancreas models with different levels of aggression,” Proc. SPIE, 73805F-73805F (2009), doi: 10.1117/12.823214.
• K. S. Samkoe, S. C. Davis, S. Srinivasan, J. A. O’Hara, T. Hasan, and B. W. Pogue, “A study of MRI-guided diffuse fluorescence molecular tomography for monitoring PDT effects in pancreas cancer,” Proc. SPIE, 73803M-73803M (2009), doi: 10.1117/12.823079.
• C. B. Warren, S. Lohser, S. Chang, P. A. Bailin, E. V. Maytin, “In-vivo fluorescence dosimetry of aminolevulinate-based protoporphyrin IX (PpIX) accumulation in human nonmelanoma skin cancers and precancers,” Proc. SPIE  7380, 73801M (July 13, 2009); doi: 10.1117/12.822966.
• S. Anand, G. Honari, A. Paliwal, T. Hasan, E. V. Maytin, “Enhancement of tumor responsiveness to aminolevulinate-photodynamic therapy (ALA-PDT) using differentiation-promoting agents in mouse models of skin carcinoma,” Proc. SPIE  7380, 73804B (2009); doi: 10.1117/12.822972.
• E. V. Maytin, S. Anand, C. Baran, G. Honari, S. Lohser, A. Kyei, P. Bailin, B. W. Pogue, “Enhancement and optimization of PpIX-based photodynamic therapy of skin cancer: translational studies from bench to clinic,” Proc. SPIE  7164, 71640K (February 23, 2009); doi: 10.1117/12.808174.

2008

• S. L. Gibbs-Strauss, S. C. Davis, J. A. O’Hara, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Noninvasive murine glioma detection improved following photobleaching of skin PpIX fluorescence,” Proc. SPIE, 68450D-68450D (2008), doi: 10.1117/12.762997.
• V. Krishnaswamy, P. J. Hoopes, K. S. Samkoe, and B. W. Pogue, “A raster scanning reflectance imager for non-model based quantification of tissue scatter,” Proc. SPIE, 686402-686402 (2008), doi: 10.1117/12.761780.
• T. Monahan, S. Jiang, and B. Pogue, “Fluorescence quantum yield of verteporfin is independent of oxygen,” Proc. SPIE, 684517-684517 (2008), doi: 10.1117/12.764244.

2005-2007

• E. V. Maytin, S. Anand, N. Sato, B. Moore, J. Mack, C. Gasbarre, S. Keevey, B. Ortel, A. Sinha, and A. Khachemoune, “Nuclear transcription factors: a new approach to enhancing cellular responses to ALA-mediated photodynamic therapy”, Proc. SPIE 6139, 613909 (2006), doi: 10.1117/12.646880.
• E. V. Maytin, S. Anand, N. Sato, J. Mack, and B. Ortel, “Harnessing cellular differentiation to improve ALA-based photodynamic therapy in an artificial skin model”, Proc. SPIE 5689, 318 (2005), doi: 10.1117/12.601940.